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Introduction
Dendritic spines are highly specialized microscopic protrusions on 
dendrites that typically have an enlarged head connected to the 
dendritic shaft by a narrow neck (Hering and Sheng, 2001; Ethell 
and Pasquale, 2005). Dendritic spines are the primary site where 
the postsynaptic components of excitatory synapses are located in 
the mammalian central nervous system. The spine neck serves to 
compartmentalize Ca
2+ in the spine head away from the dendritic 
shaft, thus modulating excitatory synaptic transmission (Nimchinsky 
et al., 2002; Korkotian et al., 2004; Noguchi et al., 2005).
The formation and maintenance of dendritic spines require 
the coordinated activity of structural and signaling molecules 
(Ethell and Pasquale, 2005; Kennedy et al., 2005). Particularly 
important are proteins involved in the regulation of actin fi  la-
ments, which are the main cytoskeletal component of spines that 
help defi  ne their shape (Matus, 2000). Time-lapse imaging has 
revealed that dendritic spines are dynamic structures that can 
undergo actin-based shape modifi  cations and, in some cases, 
can form and disassemble within minutes (Matus, 2000; Hering 
and Sheng, 2001; Bonhoeffer and Yuste, 2002; Segal, 2005). 
Spine remodeling also occurs during the physiological stimula-
tion of synapses and is correlated with changes in the strength 
of synaptic transmission. Structural reorganization of spines 
could be important for cognitive processes such as learning and 
memory (Yuste and Bonhoeffer, 2001; Nimchinsky et al., 2002; 
Segal, 2005). Indeed, several cognitive disorders are associated 
with spine malformations and changes in spine density (Fiala 
et al., 2002; Ethell and Pasquale, 2005). Thus, molecular dis-
section of the mechanisms involved in regulating dendritic spine 
morphology could be critical for understanding cognitive func-
tion and pathological conditions of the brain.
The Eph family of receptor tyrosine kinases and their 
ligands, the ephrins, play critical roles in both the developing and 
mature nervous system (Kullander and Klein, 2002; Poliakov 
et al., 2004; Yamaguchi and Pasquale, 2004; Pasquale, 2005). 
Eph receptors and ephrins interact at sites of cell–cell contact, 
where both are anchored to the cell surface. Ligand–receptor 
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emodeling of dendritic spines is believed to modu-
late the function of excitatory synapses. We previ-
ously reported that the EphA4 receptor tyrosine 
kinase regulates spine morphology in hippocampal pyra-
midal neurons, but the signaling pathways involved were 
not characterized (Murai, K.K., L.N. Nguyen, F. Irie, 
Y. Yamaguchi, and E.B. Pasquale. 2003. Nat. Neurosci. 
6:153–160). In this study, we show that EphA4 activation 
by ephrin-A3 in hippocampal slices inhibits integrin down-
stream signaling pathways. EphA4 activation decreases 
tyrosine phosphorylation of the scaffolding protein Crk-
associated substrate (Cas) and the tyrosine kinases focal 
adhesion kinase (FAK) and proline-rich tyrosine kinase 2 
(Pyk2) and also reduces the association of Cas with the Src 
family kinase Fyn and the adaptor Crk. Consistent with 
this, EphA4 inhibits β1-integrin activity in neuronal cells. 
Supporting a functional role for β1 integrin and Cas in-
activation downstream of EphA4, the inhibition of integrin 
or Cas function induces spine morphological changes similar 
to those associated with EphA4 activation. Furthermore, 
preventing β1-integrin inactivation blocks the effects of 
EphA4 on spines. Our results support a model in which 
EphA4 interferes with integrin signaling pathways that 
stabilize dendritic spines, thus modulating synaptic inter-
actions with the extracellular environment.
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engagement elicits bidirectional signals: forward signals are 
generated through the Eph cytoplasmic region, including the 
tyrosine kinase domain, and reverse signals are communicated by 
the ephrin through cytoplasmic signaling molecules. Eph recep-
tors and ephrins modify cell shape and movement by reorganizing 
the actin cytoskeleton. Several recent studies have shown 
that signaling by EphB receptors regulates dendritic spine mor-
phogenesis, a process whereby the long and thin dendritic fi  lo-
podial protrusions of immature neurons are replaced by dendritic 
spines in more mature neurons (Ethell et al., 2001; Henkemeyer 
et al., 2003; Penzes et al., 2003; Yamaguchi and Pasquale, 2004). 
Among the Eph receptors of the A class, EphA4 has been shown 
to regulate dendritic spine morphological plasticity in the adult 
hippocampus (Murai et al., 2003).
Signaling by EphA4, which is expressed on dendritic 
spines of pyramidal neurons, reduces spine length and density 
in acute hippocampal slices. A ligand for EphA4 in the hippo-
campus is ephrin-A3, which is glycosyl-phosphatidylinositol 
linked and localized on the surface of the astrocytic processes 
that surround spines. The molecular interplay between EphA4 
and its ligand ephrin-A3 likely mediates a form of cell contact–
dependent communication between astrocytes and neurons that 
helps to maintain the organization and architecture of dendritic 
spines by restricting their ability to grow and change shape 
(Murai et al., 2003). Indeed, EphA4 knockout mice have dis-
organized, longer, and more numerous spines than wild-type 
mice. Spine defects also accompany the introduction of a kinase-
inactive form of EphA4 in pyramidal neurons, suggesting that 
kinase-dependent signals are involved in spine regulation. 
Therefore, identifying the signaling pathways that are activated 
downstream of EphA4 is important for understanding how 
dendritic spines can be structurally modifi  ed by cell surface 
receptors as well as for elucidating aspects of neuron–glia 
communication. In this study, we show that EphA4 regulates 
the morphological plasticity of dendritic spines by modulating 
integrin activity and downstream signaling molecules.
Results
Ephrin-A3 stimulation inhibits 
Fyn association with a 120-kD tyrosine-
phosphorylated protein
To investigate EphA4 signaling pathways involved in the regu-
lation of dendritic spine morphology, we stimulated acute slices 
from postnatal mouse hippocampus with the ephrin-A3 ligand. 
Ephrin-A3 Fc, a soluble dimeric form of ephrin-A3, increased 
the tyrosine phosphorylation of EphA4 (Murai et al., 2003) and 
several other proteins (Fig. 1 a).
Src and Fyn are nonreceptor tyrosine kinases of the Src 
family that function downstream of EphA receptors and regu-
late the actin cytoskeleton (Ellis et al., 1996; Zisch et al., 1998; 
Bromann et al., 2004; Knoll and Drescher, 2004). Fyn in par-
ticular is present in mature synapses, plays a role in synaptic 
plasticity, is required for spatial learning and memory, and is 
needed for maintenance of dendritic spines (Grant et al., 1992; 
Morita et al., 2006). Interestingly, we found that an  120-kD 
tyrosine-phosphorylated protein (or proteins) coprecipitated 
with Fyn but not Src from hippocampal slices (Fig. 1 b), and 
ephrin-A3 Fc stimulation decreased the phosphotyrosine signal 
(Fig. 1 b). This suggests that one or more Fyn-associated proteins 
are dephosphorylated or become uncoupled from Fyn upon 
EphA receptor activation by ephrin in hippocampal slices. On 
the other hand, we did not detect changes in Fyn activation after 
ephrin-A3 Fc stimulation (Fig. 1 c).
EphA4 activation by ephrin-A3 decreases 
Cas phosphorylation and association with 
Fyn and Crk
To identify the tyrosine-phosphorylated proteins associated 
with Fyn, we examined the interaction of Fyn with  120-kD 
proteins known to bind Src family kinases, including the two 
closely related nonreceptor tyrosine kinases focal adhesion 
  kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2), and the 
Figure 1.  Ephrin-A3 Fc treatment of hippocampal slices decreases the association of Fyn with a 120-kD tyrosine-phosphorylated protein. (a) Ephrin-A3 Fc 
increases the tyrosine phosphorylation of several proteins in P6 mouse hippocampal slices, as indicated by the arrows. (b) A tyrosine-phosphorylated  120-kD 
band is detected in Fyn immunoprecipitates from postnatal day 10 hippocampal slices and is less prominent after ephrin-A3 Fc stimulation. The 120-kD band 
is not detectable in Src immunoprecipitates under the same experimental conditions. Control immunoprecipitates were with nonimmune antibodies (Ig). 
(c) Ephrin-A3 Fc stimulation of hippocampal slices does not affect Fyn activity. Fyn immunoprecipitates (IP) from Fc- and ephrin-A3 Fc–treated P12 hippocampal 
slices were probed with phosphospeciﬁ  c antibodies that recognize activated Fyn (pY416) and were reprobed with antibodies to Fyn. Fig. S1 (available at 
http://www.jcb.org/cgi/content/full/jcb.200610139/DC1) shows quantiﬁ  cation and statistical analysis of the data shown in panels b and c.EPHA4 INHIBITS INTEGRIN SIGNALING PATHWAYS • BOURGIN ET AL. 1297
scaffolding protein Crk-associated substrate (Cas). Probing Fyn 
immunoprecipitates from hippocampal lysates for FAK or Pyk2 
did not reveal a reproducible association (Fig. 2 a), although in 
some experiments, weak signals for FAK and Pyk2 were detect-
able (Fig. 2 a and not depicted). In contrast, substantial amounts 
of Cas coprecipitated with Fyn (Fig. 2 b). Both the SH2 and SH3 
domains of Src family kinases can associate with the Src-binding 
domain of Cas (O’Neill et al., 2000; Bouton et al., 2001). Treat-
ment of hippocampal slices with ephrin-A3 Fc decreased Cas 
binding to the SH2 domain of Fyn alone or fused with the SH3 
domain in pull-down experiments (Fig. 2 c) and inhibited Cas 
association with full-length Fyn in coimmuno  precipitation 
experiments (Fig. 2 d).
As expected from the reduced Cas–Fyn association 
(Nakamoto et al., 1996; Ruest et al., 2001), ephrin-A3 Fc also de-
creased Cas tyrosine phosphorylation (Fig. 2 e). This inhibition 
of Cas phosphorylation was not observed in hippocampal slices 
from EphA4 knockout mice (Fig. 2 f and Fig. S2, available 
at http://www.jcb.org/cgi/content/full/jcb.200610139/DC1), 
suggesting that EphA4 is the main EphA receptor responsible 
for the effects of ephrin-A3 Fc in hippocampal slices. The reason 
for the lower basal levels of Cas phosphorylation in the EphA4 
knockout slices remains to be determined.
Using a phosphospecifi  c antibody, we found that ephrin-
A3 Fc stimulation decreased phosphorylation of the substrate 
domain of Cas (Fig. 3 a), which contains multiple YxxP motifs. 
Figure 2.  Ephrin-A3 stimulation regulates the association of 
Fyn with Cas. (a and b) Lysates from P12 acute hippocampal 
slices were used for immunoprecipitation with Fyn antibodies. 
The immunoprecipitates were then probed with Fyn and FAK, 
Pyk2, or Cas antibodies as indicated. (c) Ephrin-A3 Fc reduces 
Cas binding to the SH2 and SH3 domains of Fyn. Lysates were 
incubated with equal amounts of puriﬁ  ed GST fusion proteins 
containing the Fyn SH2 or SH2 and SH3 domains or only GST 
as a control. Bound proteins were probed with Cas antibodies. 
(d) Ephrin-A3 Fc decreases Fyn–Cas association, as shown by 
probing Fyn immunoprecipitates with Cas and Fyn antibodies. 
(e) Ephrin-A3 Fc decreases Cas tyrosine phosphorylation, as 
shown by probing Cas immunoprecipitates with phosphot-
yrosine antibodies (PTyr) and Cas antibodies. (f) Ephrin-A3 Fc 
decreases Cas tyrosine phosphorylation in hippocampal slices 
from EphA4
+/+ mice but not in slices from EphA4
−/− mice. 
Lysates from EphA4
+/+ or EphA4
−/− hippocampal slices were 
stimulated with ephrin-A3 Fc or Fc as a control. Cas immuno-
precipitates were probed with phosphotyrosine antibodies (PTyr) 
and reprobed with Cas antibodies. Fig. S1 shows quantiﬁ  ca-
tion and statistical analysis of the data shown in panels c–e. 
Fig. S2 (available at http://www.jcb.org/cgi/content/full/
jcb.200610139/DC1) shows quantiﬁ  cation of the data in panel f 
and an additional experiment similar to the one shown in panel f.
Figure 3.  Ephrin-A3 regulates Cas phosphorylation in the substrate domain and association with Crk. (a) Ephrin-A3 Fc decreases the phosphorylation of 
Cas in the substrate domain. Cas immunoprecipitates from Fc- or ephrin-A3 Fc–treated hippocampal slices were probed with antibodies recognizing several 
tyrosine phosphorylation sites in the Cas substrate domain (Fonseca et al., 2004) and reprobed with antibodies to Cas. (b) Ephrin-A3 Fc decreases Cas 
binding to the SH2 domain of Crk. Equal amounts of GST-Crk SH2 domain and GST (as a control) were incubated with lysates from Fc- or ephrin-A3 Fc–
treated hippocampal slices and probed with Cas antibodies. (c) Ephrin-A3 Fc reduces Crk–Cas association, as shown by probing Crk immunoprecipitates 
with Cas antibodies. (d) Ephrin-A3 Fc does not affect Crk phosphorylation on tyrosine 221, as shown by probing Crk immunoprecipitates with phospho-
speciﬁ  c antibodies (pY221). Fig. S1 (available at http://www.jcb.org/cgi/content/full/jcb.200610139/DC1) shows quantiﬁ  cation and statistical analysis 
of the data shown in panels a–d.JCB • VOLUME 178 • NUMBER 7 • 2007  1298
When phosphorylated, these motifs mediate binding of the SH2 
domain of the adaptor protein Crk, which is an important ef-
fector of Cas (Feller, 2001; Chodniewicz and Klemke, 2004). 
Indeed, ephrin-A3 Fc treatment inhibited Cas binding to Crk in 
pull-down (Fig. 3 b) and coimmunoprecipitation experiments 
(Fig. 3 c). Phosphorylation of Crk on tyrosine 221 is also known 
to negatively regulate Crk interaction with Cas (Feller, 2001), 
but ephrin stimulation did not affect the phosphorylation of this 
site (Fig. 3 d). Thus, EphA4-induced dephosphorylation of Cas 
in the hippocampus disrupts Cas complexes.
Cas regulates dendritic spine morphology
Cas is a well-known regulator of cell shape and motility (O’Neill 
et al., 2000; Bouton et al., 2001) and, therefore, may play a role 
in dendritic spine regulation downstream of EphA4. Indeed, 
both EphA4 and Cas are present in brain synaptosomal prepa-
rations, including the postsynaptic density (PSD) fraction 
(Fig. 4 a). Furthermore, Cas expression in primary hippocampal 
neurons but not in glial cells (Fig. 4 b) supports the idea that Cas 
is involved in EphA4 forward signals that control dendritic 
spine morphology.
Biolistic transfection of a pool of four Cas siRNAs or 
  individual Cas siRNAs in cultured hippocampal slices caused 
a substantial decrease in dendritic spine density (30–45%; Fig. 5) 
and a small but signifi  cant decrease in spine length (13–16%; 
P < 0.01) compared with transfection with control siRNAs that 
do not knock down Cas expression (Fig. 5 and Fig. S3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200610139/DC1). 
Cas siRNA transfection also decreased the number of mushroom-
shaped spines, which represent the most common category of 
spines in hippocampal pyramidal neurons, and increased the 
number of stubby spines (Fig. 5). These effects were caused 
by the down-regulation of Cas expression because they were 
abolished when human Cas was cotransfected with a mouse-
specifi  c Cas siRNA (Fig. S4). Expression of the different Cas 
siRNAs did not detectably affect the overall morphology of the 
pyramidal neurons (unpublished data). These results implicate 
Cas as an important regulator of dendritic spines.
To identify the functional domains of Cas that play a role in 
dendritic spines, we transfected Cas deletion mutants (Fig. 6 a). 
Spine density was reduced by 48% in pyramidal neurons ex-
pressing the Cas∆SB mutant (which lacks the Src-binding 
domain) and by 47% in neurons expressing the Cas∆SH3 mutant 
(Fig. 6, a and b). In contrast, transfection of a Cas mutant that 
lacks the substrate domain (Cas∆SD) and, therefore, cannot 
bind Crk did not signifi  cantly affect spine density (P > 0.05; 
Fig. 6, a and b). Spine length and width were not signifi-
cantly affected by any of the Cas mutants (P > 0.05), with the 
exception of a small increase in spine width in the neurons 
transfected with Cas∆SH3 and Cas∆SB. With regard to spine 
shape, the Cas∆SH3 and Cas∆SB mutants caused a decrease in 
mushroom spines and a prominent increase in stubby spines, 
whereas Cas∆SD decreased mushroom spines while increasing 
thin spines (Fig. 6 c). These results suggest that protein inter-
actions mediated by the Cas SH3 and Src-binding domains con-
tribute to maintaining spine density and play a role in defi  ning 
spine shape.
Ephrin-A3 inhibits 𝗃1-integrin activity 
in neuronal cells
The Cas SH3 domain is known to be a docking site for the FAK 
and Pyk2 kinases (O’Neill et al., 2000; Bouton et al., 2001), and 
we found that treatment of hippocampal slices with ephrin-A3 
Fc decreases both FAK and Pyk2 tyrosine phosphorylation (Fig. 7, 
a and b). Because FAK, Pyk2, and Cas all become tyrosine 
phosphorylated upon integrin-mediated adhesion (Girault et al., 
1999; Playford and Schaller, 2004), the coordinated decrease 
in their phosphorylation suggested that EphA4 activation may 
suppress integrin activity. Indeed, ephrin-A3 Fc stimulation 
of the hippocampal HT22 neuronal cell line, which expresses 
endog  enous EphA4, caused a 35% decrease in cell attachment 
to surfaces coated with the integrin ligand fi  bronectin, whereas 
the integrin-independent attachment to poly-l-lysine was not 
affected (Fig. 7 c). Similar results were obtained with the neuronal-
like B35 cell line, which stably expresses EphA4 (Fig. 7 d). 
Concurrent with the reduction in cell attachment, ephrin-A3 Fc 
stimulation reduced the level of Cas tyrosine phosphorylation 
in both cell lines (Fig. 7, c and d), which is similar to the effect 
observed in hippocampal slices.
Integrins are heterodimers containing an α and β subunit, 
and integrins containing the β1 subunit are highly expressed in 
the brain and infl  uence hippocampal synaptic plasticity (Pinkstaff 
et al., 1999; Clegg et al., 2003; Chan et al., 2006; Z. Huang et al., 
2006). To determine whether EphA4 may inactivate β1 integrins, 
we used the 9EG7 antibody, which, at low concentrations, detects 
Figure 4.  Cas is expressed in hippocampal neurons and enriched in the 
PSD. (a) Subcellular localization of EphA4 and Cas in a synaptosomal 
preparation from adult mouse brain. Equal amounts of protein from the 
  indicated fractions were probed for EphA4, Cas, PSD-95 (postsynaptic 
marker), syntaxin (presynaptic marker), and the tyrosine phosphatase SHP2 
(control present in all fractions). PSD, postsynaptic density fraction. (b) Cas 
is expressed in cultured hippocampal neurons but not in glial cells. Cas ex-
pression was detected by immunoblotting lysates from adult mouse brain 
and primary hippocampal neurons and glial cells.EPHA4 INHIBITS INTEGRIN SIGNALING PATHWAYS • BOURGIN ET AL. 1299
the ligand-occupied (active) conformation of β1 integrins with-
out interfering with the binding of extracellular matrix ligands 
(Bazzoni et al., 1995). Ephrin-A3 Fc treatment of HT22 cells 
caused a strong decrease in 9EG7 antibody binding (Fig. 7 e) 
without affecting the cell surface levels of β1 integrins, as deter-
mined by surface protein biotinylation (Fig. 7 f). Thus, EphA4 
activation by ephrin-A3 inhibits β1-integrin activity and adhe-
sion to fi  bronectin in neurons.
Inhibition of integrin activity induces 
spine retraction
To examine whether integrins regulate dendritic spine mor-
phology, we treated cultured hippocampal slices with an inte-
grin function-blocking peptide (RGDFV) or a control peptide 
(RADFV; Fig. 8 a). Peptides containing the RGD (Arg-Gly-Asp) 
motif competitively antagonize integrin binding to extracellular 
matrix ligands (Ruoslahti, 1996; Shimaoka and Springer, 2003; 
Hama et al., 2004). Treatment of slices with the RGDFV pep-
tide signifi  cantly decreased Cas tyrosine phosphorylation (P < 
0.05; Fig. 8 b). Although RGD peptides have also been shown 
to promote integrin activation depending on the experimental 
conditions (Lin et al., 2003; Bernard-Trifi  lo et al., 2005; Shi 
and Ethell, 2006), this result is consistent with the expected 
inhibition of integrin downstream signaling pathways. The 
dendritic spines in slices treated with RGDFV peptide were 
28% shorter than those treated with the control peptide (Fig. 8, 
a and c), whereas spine width was reduced only slightly, and 
spine density was not signifi  cantly altered (P > 0.05; Fig. 8 d). 
Figure 5.  Cas knockdown decreases dendritic spine den-
sity and length. (a) Cas siRNAs effectively and selectively re-
duce Cas expression. Immunoblot analysis of Cas levels in 
NIH3T3 cells transfected with four individual Cas siRNAs 
(siCas #1–4), a pool of the four siRNAs (siCas pool), a control 
siRNA (siControl #1) or no siRNA (none). Glyceraldehyde-
3-phosphate dehydrogenase (GADPH) levels were not 
  affected. (b) Confocal images of dendrites from CA1 pyra-
midal neurons in cultured hippocampal slices cotransfected 
with the indicated siRNAs and EGFP-F as a marker. (c–e) 
Histograms show the mean spine density, length, and width 
of neurons transfected with Cas siRNAs. Densities are as 
follows: 0.75 ± 0.02 spines/μm (control #1), 0.49 ± 
0.03 spines/μm (siCas pool), 0.38 ± 0.04 spines/μm 
  (siCas #1), and 0.51 ± 0.04 spines/μm (siCas #4). 
Lengths are as follows: 1.24 ± 0.01 μm (control #1), 1.04 ± 
0.01 μm (siCas pool), 1.07 ± 0.02 μm (siCas #1), and 
1.07 ± 0.02 μm (siCas #4). (f) Percentage of spines in the 
indicated morphological categories. Statistical analysis was 
performed by ANOVA followed by Dunnett’s posthoc test 
for comparisons of neurons transfected with Cas siRNAs 
to neurons transfected with a control siRNA. *, P < 0.05; 
**, P < 0.01. Error bars represent SEM. A total of 
n = 709–1,525 spines from 27–42 dendrites of 8–10 CA1 
pyramidal neurons were analyzed per condition in three 
experiments. Additional experiments using a second control 
siRNA are shown in Fig. S3 (available at http://www.jcb
.org/cgi/content/full/jcb.200610139/DC1). Bars (b), 5 μm; 
(f) 1 μm.JCB • VOLUME 178 • NUMBER 7 • 2007  1300
The shape of spines treated with the RGDFV peptide shifted 
from a mushroom-shaped to a stubby appearance (Fig. 8 e). 
These results show that integrin activity is required to maintain 
proper spine length and suggest that suppression of integrin 
function could play an important role in the effects of EphA4 
on dendritic spine morphology.
Sustained 𝗃1-integrin activation blocks 
the effects of EphA4 on dendritic spines
To prevent β1-integrin inactivation during ephrin-A3 Fc stimu-
lation, we treated acute hippocampal slices with high concen-
trations of the 9EG7 antibody. The antibody alone did not affect 
dendritic spine length, density, or width (Fig. 9, a–d; compare 
Fc with β1-Ab/Fc). As previously shown (Murai et al., 2003), 
treatment of hippocampal slices with ephrin-A3 Fc caused a 
 signifi  cant decrease in spine length (P < 0.001; Fig. 9, a and b) 
and density (Fig. 9 c), with minor effects on spine width (Fig. 9 d, 
compare Fc with A3-Fc). In addition, as we show here, ephrin-A3 
Fc decreased the proportion of mushroom-shaped spines while 
increasing stubby spines (Fig. 9 f). Remarkably, the 9EG7 anti-
body completely blocked all of the effects of ephrin-A3 Fc 
on the spines (Fig. 9, a–d; compare β1-Ab/Fc with β1-Ab/ 
ephrin-A3 Fc). This is consistent with the lack of detectable Cas 
  dephosphorylation when ephrin-A3 Fc was used together with the 
9EG7 antibody (Fig. 9 e), although the antibody itself decreased 
Cas phosphorylation. We obtained very similar results when we 
treated hippocampal slices with the divalent cation Mn
2+, which 
is known to promote the activation of many integrins, including 
Figure 6.  The Cas SH3 and Src-binding do-
mains are important for the regulation of spine 
morphology. (a) Confocal images of dendrites 
from CA1 pyramidal neurons in hippocampal 
slices cotransfected with the indicated Cas con-
structs and EGFP-F as a marker. On the right 
are schematic representations of the constructs 
used for the transfections, including wild-type Cas, 
Cas∆SD (Cas lacking the substrate domain), 
Cas∆SH3 (Cas lacking the SH3 domain), and 
Cas∆SB (Cas lacking the Src-binding domain). 
(b) Quantitative analysis of dendritic spine para-
meters in transfected neurons. Densities are as 
follows: 0.52 ± 0.02 spines/μm (control), 
0.62 ± 0.02 spines/μm (Cas wild type), 0.53 ± 
0.03 spines/μm (Cas∆SD), 0.27 ± 0.02 
spines/μm (Cas∆SH3), and 0.27 ± 0.03 
spines/μm (Cas∆SB). (c) Percentage of spines 
in the indicated morphological categories. 
Statistical analysis was performed by ANOVA 
followed by Dunnett’s posthoc test for com-
parisons of neurons transfected with Cas con-
structs to control-transfected neurons. *, P < 0.05; 
**, P < 0.01. Error bars represent SEM. A total 
of n = 478–2,182 spines from 23–53 dendrites 
of 6–10 CA1 neurons were analyzed per condi-
tion in three experiments. Bar, 5 μm.EPHA4 INHIBITS INTEGRIN SIGNALING PATHWAYS • BOURGIN ET AL. 1301
β1 integrins (Fig. S5, available at http://www.jcb.org/cgi/content/
full/jcb.200610139/DC1; Ivins et al., 2000; Arnaout et al., 2005). 
Thus, preventing β1-integrin inactivation counteracts the ef-
fects of EphA4 on dendritic spines.
Discussion
This study provides the fi  rst direct evidence that EphA recep-
tors regulate β1-integrin activity and downstream signaling 
pathways in neurons, which is crucial for governing the mor-
phological plasticity of dendritic spines. Activation of EphA4 
by ephrin-A3 may disrupt critical integrin-mediated attachment 
to the extracellular matrix and cell surface integrin ligands, thus 
inhibiting integrin signaling to Cas and other downstream sig-
naling proteins. Inhibition of integrin function with an RGD 
antagonistic peptide and inhibition of Cas function with siRNAs 
decreased spine length and the proportion of mushroom-shaped 
spines while increasing stubby spines in hippocampal slices. 
These spine morphological changes are strikingly similar to 
those elicited by EphA4 activation with ephrin-A3 Fc, which is 
consistent with the idea that the different manipulations affect 
components of a common signaling pathway. However, the RGD 
peptide did not decrease spine density, suggesting that integrin 
inhibition by the peptide down-regulates Cas function less dras-
tically than Cas siRNAs or that it may affect additional Cas-
independent pathways.
Figure 7.  EphA4 activation by ephrin-A3 Fc inhibits 𝗃1 
integrin–mediated adhesion. (a and b) Ephrin-A3 Fc de-
creases the tyrosine phosphorylation of FAK (a) and Pyk2 
(b) in P12 hippocampal slices. Immunoprecipitated FAK 
and Pyk2 were probed by immunoblotting with an anti-
phosphotyrosine (PTyr) antibody and reprobed with FAK 
or Pyk2 antibodies. (c and d) Ephrin-A3 Fc decreases 
attachment of the HT22 hippocampal cell line and the 
neuronal-like EphA4 B35 cell line to ﬁ  bronectin (FN) but not 
to poly-L-lysine (PLL). Ephrin-A3 Fc also reduces Cas tyrosine 
phosphorylation in both cell lines. Immunoprecipitated 
Cas was probed by immunoblotting with an antiphospho-
tyrosine (PTyr) antibody and reprobed with a Cas anti-
body. (e) Ephrin-A3 Fc decreases the levels of active β1 
integrin in cultured neuronal cells. HT22 cells plated on 
ﬁ  bronectin and stimulated with ephrin-A3 Fc, Fc, or Mn
2+ 
(an ion known to promote integrin activation) were incu-
bated with a low concentration (2 μg/ml) of rat 9EG7 anti-
body or IgG (control) to detect active β1 integrin. The 
bound antibodies were detected by immunoblotting with 
an anti–rat antibody. For quantiﬁ  cation of active β1 integrin, 
the signal in the Ig lane (background) was subtracted 
from the signal in the β1 lane and normalized to total 
β1 integrin. (f) Ephrin-A3 Fc does not affect the levels of 
β1 integrins on the cell surface. Cells were treated as de-
scribed in panel e, and surface proteins were labeled with 
biotin, isolated with streptavidin beads, and probed by 
immunoblotting with an anti–β1-integrin antibody. Immuno-
blotting of the cell lysates shows similar levels of total 
β1 integrin. Statistical analyses were performed by ANOVA 
followed by Tukey’s posthoc test (c and d) or Dunnett’s 
posthoc test (e). **, P < 0.01; ***, P < 0.001 for com-
parison with Fc-treated cells. Error bars indicate SEM from 
three independent experiments. Fig. S1 (available at http://
www.jcb.org/cgi/content/full/jcb.200610139/DC1) 
shows quantiﬁ  cation and statistical analysis of the data shown 
in panels a–d and f. JCB • VOLUME 178 • NUMBER 7 • 2007  1302
Several studies have shown that Eph receptor forward sig-
naling modulates the adhesion and migration of nonneuronal 
cells by affecting integrin function (Table S1 in Pasquale, 2005). 
Both positive and negative effects of Eph receptors on integrin-
mediated adhesion have been reported, depending on the recep-
tor involved and the cellular context. The interplay between Eph 
receptors and integrins may involve a direct physical associa-
tion, as reported for EphA4 and αIIbβ3 integrin in platelets 
(Prevost et al., 2005).
Many integrin α and β subunits are expressed in the brain 
(Pinkstaff et al., 1999; Clegg et al., 2003). Among them, the β1 
subunit, which can associate with various α subunits, is found 
in brain synaptosomal preparations and in the dendritic spines 
of cultured hippocampal neurons (Schuster et al., 2001; Clegg 
et al., 2003; Shi and Ethell, 2006). Signals mediated by integrins, 
including β1, have been shown to increase the length and den-
sity of dendritic protrusions and promote synapse formation 
and remodeling in cultured hippocampal neurons (Hama et al., 
2004; Shi and Ethell, 2006). Furthermore, siRNA knockdown 
of the α5- or β1-integrin subunits in hippocampal neurons has 
been shown to decrease the number of dendritic protrusions 
and synapses (Webb et al., 2007; D.J. Webb, H. Zhang, and 
A.F. Horwitz. 2005. Society for Neuroscience. Abstr. 501.5). These 
fi  ndings are consistent with the idea that integrin inactivation 
contributes to the effects of EphA4 on dendritic spine morphology 
and density. The ability of a β1 integrin–activating antibody to 
block spine retraction downstream of EphA4 and the observed 
inhibition of β1-integrin activity by EphA4 suggest that integrins 
containing the β1 subunit play a particularly important role 
downstream of EphA4.
It is noteworthy that inhibiting integrin function with RGD 
peptides through the use of integrin function–blocking anti-
bodies or by targeted gene deletion has been shown to cause 
defects in long-term potentiation (LTP), a form of synaptic plas-
ticity (Chun et al., 2001; Chan et al., 2006; Z. Huang et al., 2006; 
Kramar et al., 2006). The effects of integrin inactivation 
on synaptic plasticity have been associated with decreased 
N-methyl-d-aspartate (NMDA) receptor function and defects 
in actin polymerization (Lin et al., 2003; Kramar et al., 2006). 
It will also be interesting to examine whether the changes in spine 
shape induced by integrin inactivation may have a functional 
impact on synaptic transmission and plasticity. Recent fi  ndings 
suggest that the induction of LTP, which is dependent on an in-
crease in cytosolic Ca
2+ concentration, may be more diffi  cult to 
achieve in dendritic spines with thick neck regions such as 
stubby spines as a result of the faster dispersion of Ca
2+ ions 
into the dendritic shaft (Nimchinsky et al., 2002; Korkotian et al., 
2004; Noguchi et al., 2005). Inhibition of integrin activity may 
therefore moderate LTP induction and stabilization by EphA4 
(Grunwald et al., 2004).
Consistent with a role of integrins in dendritic spine reg-
ulation and synaptic physiology, the extracellular matrix has 
Figure 8.  Integrin activity regulates spine mor-
phology. (a) Dendritic spines of pyramidal neu-
rons have shorter spines when treated with RGD 
peptide than when treated with control RAD (Arg-
Ala-Asp) peptide. Cultured hippocampal slices 
transfected with EGFP-F as a marker were incu-
bated for 24 h with 170 μM RAD or 170 μM 
RGD peptide. Representative confocal micro-
graphs of dendrites from transfected CA1 pyrami-
dal neurons are shown. (b) Cas is dephosphorylated 
in RGD-treated hippocampal slices. Lysates from 
cultured hippocampal slices treated as described 
in panel a were used to immunoprecipitate Cas, 
and the immunoprecipitates were probed with 
phosphotyrosine antibodies (PTyr) and reprobed 
with Cas antibodies. For quantiﬁ  cation, Cas phos-
phorylation levels were normalized to the total 
amount of Cas immunoprecipitated and to the 
RAD control condition. The histogram represents 
mean ± SEM from three experiments. *, P < 0.05 
by  t test. (c) Quantiﬁ   cation of spine length in 
RGD- and RAD-treated slices: 1.28 ± 0.02 μm for 
RAD  versus 0.95 ± 0.01 μm for RGD. P < 
0.001 (Kolmogorov-Smirnov test and t test). 
(d) Quantiﬁ  cation of spine density and spine width. 
(e) Morphological categories of spines. Statistical 
analyses were performed with the t test. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001 for comparison 
between RGD- and RAD-treated spines. A total of 
n = 1,250–1,700 spines from 36–56 dendrites 
of 8–13 CA1 neurons were analyzed per condi-
tion in three experiments. Error bars indicate SEM. 
Bar, 5 μm.EPHA4 INHIBITS INTEGRIN SIGNALING PATHWAYS • BOURGIN ET AL. 1303
also been shown to influence spine morphological plasticity. 
For example, mutant mice that have reduced levels of reelin, 
a large secreted glycoprotein that binds to the α3β1 integrin, 
have fewer and shorter spines compared with wild-type mice 
(Liu et al., 2001). Furthermore, degradation of extracellular 
  matrix proteins by tissue plasminogen activator, which likely 
reduces integrin activity, has been implicated in the struc-
tural remodeling of spines that occurs in the visual cortex 
during experience-dependent plasticity (Mataga et al., 2004; 
Oray et al., 2004). Whether EphA4 may inhibit integrin activity 
by promoting proteolytic degradation of the extracellular matrix 
remains to be determined.
We have found that integrin inactivation by EphA4 results 
in the disassembly and inactivation of integrin signaling com-
plexes, including the dissociation of Cas–Fyn complexes and 
the dephosphorylation of Cas, FAK, and Pyk2. The phosphatase 
mediating these dephosphorylation events remains unknown, 
although the tyrosine phosphatase SHP2 has been previously 
Figure 9. Preventing  𝗃1-integrin inactivation counteracts ephrin-A3 Fc–induced spine retraction. (a) Postnatal day 23–25 acute hippocampal slices were 
pretreated with a high concentration (20 μg/ml) of the 9EG7 antibody to promote β1-integrin activation before stimulation with ephrin-A3 Fc or Fc as 
a control. Representative confocal micrographs of DiI-labeled dendritic spines of CA1 pyramidal neurons are shown. (b) Quantitative analysis of dendritic 
spine length. Lengths are as follows: 1.14 ± 0.01 μm for Fc versus 0.97 ± 0.01 μm for A3-Fc (P < 0.0001 by Kolmogorov-Smirnov test and P < 0.001 
by ANOVA and Bonferroni’s posthoc test) and 1.10 ± 0.01 μm for β1-Ab/Fc versus 1.15 ± 0.01 μm for β1-Ab/ephrin-A3-Fc (P > 0.05 by Kolmogorov-
Smirnov test, ANOVA, and Bonferroni’s posthoc test). (c) Quantitative analysis of dendritic spine density. Densities are as follows: 1.16 ± 0.05 spines/μm 
for Fc versus 0.77 ± 0.03 spines/μm for A3-Fc and 1.10 ± 0.04 spines/μm for β1-Ab/Fc versus 1.13 ± 0.06 spines/μm for β1-Ab/ephrin-A3-Fc. 
(d) Quantitative analysis of dendritic spine width. (e) Treatment with the 9EG7 antibody prevents Cas dephosphorylation after ephrin-A3 Fc treatment. Lysates 
from hippocampal slices treated as described in panel a were used to immunoprecipitate Cas, and the immunoprecipitates were probed with phosphotyro-
sine antibodies (PTyr) and reprobed with Cas antibodies. (f) Morphological categories of spines. Statistical analyses in panels c, d, and f were performed 
with multifactorial ANOVA and Tukey’s posthoc test (c and f) or Bonferroni’s posthoc test (d). *, P < 0.05; **, P < 0.01; ***, P < 0.001 for comparison 
between Fc versus ephrin-A3 Fc or for β1-Ab/Fc versus β1-Ab/ephrin-A3 Fc. In panel d, P < 0.01 for the comparison of Fc versus β1-Ab/Fc. A total 
of n = 1,071–1,341 spines from 19–24 dendrites of 9–10 CA1 neurons were analyzed per condition in three experiments. Fig. S1 (available at 
http://www.jcb.org/cgi/content/full/jcb.200610139/DC1) shows quantiﬁ  cation and statistical analysis of the data shown in panel e. Error bars indicate SEM. 
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implicated in FAK dephosphorylation downstream of an EphA 
receptor in nonneuronal cells (Miao et al., 2000).
Even though Cas is most highly expressed in the brain and 
has been detected in complex with the NMDA receptor (Husi 
et al., 2000; J. Huang et al., 2006), its role in the nervous system 
is poorly characterized. Recent data have implicated Cas in axon 
elongation in cerebellar granule neurons (J. Huang et al., 2006), 
and our data show that Cas is preferentially expressed in hippo-
campal neurons rather than glial cells and is enriched in the 
PSD fraction of synaptosomal preparations. Furthermore, Cas 
knockdown in hippocampal slices decreased dendritic spine 
density and caused changes in spine morphology. The observed 
involvement of the Src-binding and SH3 domains of Cas in 
spine regulation further suggests that Cas may cooperate with 
Fyn and kinases of the FAK family, which interact with these 
two domains, to maintain proper spine morphology.
Interestingly, we detected Cas association with Fyn but 
not Src in hippocampal tissue. Although both Src and Fyn are 
components of the PSD and of NMDA receptor complexes 
(Salter and Kalia, 2004), differences in Src and Fyn protein 
interactions in the brain have been reported (Husi et al., 2000; 
Lauri et al., 2000). Thus, the synaptic functions of these two 
closely related kinases are not completely redundant. Accord-
ingly, Fyn but not Src knockout mice demonstrate defects in the 
induction of LTP in adult CA1 hippocampal synapses (Grant 
et al., 1992; Kojima et al., 1997).
The dephosphorylation of FAK and Pyk2 that we observed 
in hippocampal slices stimulated with ephrin-A3 is consistent 
with reduced integrin function and suggests that inactivation of 
these two kinases may also contribute to spine morphological 
plasticity downstream of EphA4. However, the role of FAK in 
dendritic spines seems to be complex because FAK activation 
has been recently shown to be important for spine shortening 
and morphogenetic changes downstream of EphB receptors in 
cultured hippocampal neurons (Moeller et al., 2006).
Surprisingly, we did not detect signifi  cant changes (P > 
0.05) in dendritic spines expressing the Cas∆SD mutant, which 
does not bind Crk, except for a decrease in mushroom-shaped 
spines. Crk couples phosphorylated Cas to the guanine nucle  o-
tide exchange factor DOCK180, which activates Rac1, thus 
promoting actin polymerization and cell migration (Playford 
and Schaller, 2004). Therefore, either the Cas–Crk pathway 
does not play a major role in spine regulation or another sig-
naling pathway can compensate for the disruption of Cas–Crk 
complexes. Indeed, EphA4 activation does not affect Crk phos-
phorylation on tyrosine 221, suggesting that the adaptor function 
of Crk is not impaired by EphA4 and that molecules other than 
Cas could still recruit Crk to promote Rac1 activation (Chen 
et al., 2004).
Our results demonstrate that EphA4 function in dendritic 
spines is closely tied to the regulation of β1-integrin signaling 
pathways, but additional pathways can also infl  uence spine 
structure downstream of EphA4. For example, in neurons, EphA4 
promotes the activity of at least two exchange factors that activate 
Rho family GTPases, Ephexin-1, and Vav2 (Shamah et al., 2001; 
Cowan et al., 2005; Sahin et al., 2005). Recently, a pathway 
involving the serine-threonine kinase Cdk5 and Ephexin-1 has 
been reported to decrease dendritic spine density downstream 
of EphA4 (Fu et al., 2007). This pathway likely affects dendritic 
spines through the activation of RhoA, a GTPase that promotes 
actomyosin contraction (Bonhoeffer and Yuste, 2002; Ethell 
and Pasquale, 2005). Nevertheless, β1-integrin inactivation ap-
pears to be a crucial event because preventing it counteracts all 
EphA4-dependent spine modifi  cations. Further studies will be 
necessary to fully elucidate the Eph forward and ephrin reverse 
signaling pathways that modulate the morphological plasticity 
of excitatory synapses.
Materials and methods
Antibodies
Monoclonal antibodies to phosphotyrosine (clone 4G10), Src, PSD95, and 
polyclonal antibody to Pyk2 were obtained from Upstate Biotechnology. 
Monoclonal antibody to FAK, Cas, Crk, and β1 integrin were purchased 
from BD Biosciences. The phosphospeciﬁ  c antibodies to Crk tyrosine 221, 
Cas tyrosine 165, and Src tyrosine 416 were obtained from Cell Signaling. 
The monoclonal 9EG7 antibody to activated β1 integrin was obtained from 
BD Biosciences. Monoclonal antibodies to β-actin and syntaxin were pur-
chased from Sigma-Aldrich. Antibodies to Fyn and SHP2 and a Cas poly-
clonal antibody were purchased from Santa Cruz Biotechnology, Inc. The 
monoclonal antibody to EphA4 was obtained from Zymed Laboratories.
GST pull-down assays and immunoprecipitations
Tissues or cells were lysed in Hepes buffer (50 mM Hepes, pH 7.5, 150 mM 
NaCl, 5 mM KCl, 1 mM EDTA, 10% glycerol, and 1% Triton X-100) 
or modiﬁ   ed radioimmunoprecipitation assay buffer with 1 mM sodium 
orthovanadate, 1 mM NaF, 1 mM PMSF, and other protease inhibitors 
(Sigma-Aldrich). GST-Fyn SH2 and GST-Crk SH2 fusion proteins have been 
previously described (Zisch et al., 1998, 2000). Recombinant GST fusion 
proteins were afﬁ  nity puriﬁ  ed from Escherichia coli BL21 (Pﬁ  zer) by ad-
sorption to glutathione–Sepharose 4B beads (Pﬁ  zer). GST-Fyn SH3/SH2 
fusion protein was purchased from Santa Cruz Biotechnology, Inc. For 
GST pull-down assays, cell lysates were incubated with 10 μg GST fu-
sion proteins immobilized on glutathione beads. For immunoprecipitations, 
cell lysates were incubated with 2–5 μg of antibodies and GammaBind 
Plus Sepharose beads (GE Healthcare) for 3 h at 4°C. Protein extracts 
were separated by SDS-PAGE and probed by immunoblotting. Detection 
of HRP-conjugated secondary antibodies (GE Healthcare) was performed 
with enhanced chemiluminescence detection systems (GE Healthcare or 
Pierce Chemical Co.).
Preparation of synaptosomal fractions
All steps were performed at 4°C as described previously (Rogers and 
Lemaire, 1991). Freshly dissected adult mouse brains were homogenized 
in 10 vol of ice-cold homogenization buffer (buffer H [50 mM Tris-HCl, 
pH 7.4, 1 mM CaCl2, 1 mM MgCl2, and 1 mM NaHCO3] containing 
320 mM sucrose) using a motor-driven glass-ﬂ  uorinated ethylene polymer 
homogenizer. The homogenate was centrifuged at 700 g for 10 min to pro-
duce supernatant S1. S1 was further centrifuged at 17,000 g for 15 min 
to produce pellet P2. P2 was resuspended in homogenization buffer, 
layered on top of sucrose gradient (equal volumes of 1.2, 1.0, 0.8, and 
0.65 M sucrose in buffer H), and centrifuged at 100,000 g for 2 h. 
A turbid fraction was recovered from the 1.0 /1.2 M sucrose interface and 
resuspended in at least 2 vol of homogenization buffer. The suspension 
was centrifuged for 30 min at 100,000 g to produce the pellet P2′ 
(synaptosome fraction). P2′ was resuspended in Tris buffer (50 mM Tris-HCl, 
pH 7.4, and 1 mM EDTA with protease inhibitors), incubated for 45 min 
on ice, and centrifuged at 100,000 g for 30 min. The supernatant containing 
soluble synaptic proteins was collected (synaptic cytosol fraction). The mem-
brane pellet was resuspended in homogenization buffer, applied on top 
of a ﬁ  ve-step discontinuous sucrose gradient (1.2, 1.0, 0.8, and 0.65 M 
sucrose), and centrifuged at 100,000 g for 2 h. Pure synaptic membranes 
were recovered from the 1.2/1.0 M sucrose interface and diluted with at 
least 2 vol of homogenization buffer (synaptic membrane fraction). A pure 
membrane fraction was pelleted at 100,000 g for 30 min, resuspended 
in homogenization buffer, and mixed with an equal volume of 3% Triton 
X-100 in homogenization buffer. Membranes were incubated for 30 min 
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(soluble membrane fraction) and a Triton X-100–insoluble material pellet. 
Triton X-100–insoluble proteins were resuspended in homogenization buf-
fer containing 1.5% Triton X-100 and applied on top of a 0.83-M sucrose 
cushion. After centrifugation at 105,000 g for 1 h, PSDs were collected as 
the resulting pellet and resuspended in Tris buffer containing 0.25% Triton 
X-100 (PSD fraction). Equal amounts of protein from synaptosome, syn-
aptic cytosol, synaptic membrane, soluble membrane, and PSD fractions 
were analyzed by immunoblotting.
Neuronal and glial cultures
Primary hippocampal neurons were prepared from embryonic day 17 rat 
embryos and cultured as described previously (Zafra et al., 1990) with 
minor modiﬁ  cations. In brief, after trypsinization and mechanical dissocia-
tion, hippocampal cells were suspended in DME supplemented with 10% 
FCS and preattached on uncoated culture plates for 2 h to remove glial cells. 
Neurons recovered as nonadherent cells were plated on poly-D-  lysine– 
(50 μg/ml) and laminin (5 μg/ml)-coated plates at a density of 3 × 10
4 
cells/cm
2 in neurobasal medium supplemented with B27, L-glutamine, and 
penicillin/streptomycin. Neurons were cultured for 14 d in the presence 
of 2 μM AraC to prevent the growth of contaminating glial cells. The glial 
cells separated from the neurons by attachment on uncoated culture plates 
were cultured for 14 d in DME supplemented with 10% FCS, L-glutamine, 
and penicillin/streptomycin.
Hippocampal slice cultures
Hippocampal slices (300 μm in thickness) were prepared and stimulated 
for 45 min as previously described using the middle one third of the hippo-
campus (Stoppini et al., 1991; Murai et al., 2003). Slices were kept for 
2–5 min in MEM (Invitrogen) supplemented with 25 or 5% horse serum 
(Invitrogen), 25% HBSS (Irvine Scientiﬁ  c), and 0.65% dextrose before 
stimulation. In some experiments, 9.5 μg/ml ephrin-A3 Fc (R&D Systems) 
was preclustered with 1 μg/ml anti-Fc antibodies, which produced simi-
lar EphA4 phosphorylation and Cas dephosphorylation as unclustered 
ephrin-A3 Fc. To promote β1-integrin activation, slices were pretreated 
with 20 μg/ml 9EG7 antibody for 25 min or 500 μM Mn
2+ for 20 min before 
stimulation with Fc proteins. Slices were either lysed and analyzed by 
  immunoblotting or ﬁ  xed in 4% PFA in 0.1 M PBS for 30 min, labeled with DiI 
crystals (Invitrogen), and analyzed by confocal z-series imaging as previ-
ously described (Murai et al., 2003). EphA4 knockout mice were provided 
by A. Boyd and M. Dottori (Queensland Institute of Medical Research, 
Brisbane, Australia).
A gene gun (Helios; Bio-Rad Laboratories) was used to transfect plas-
mids into pyramidal neurons. Hippocampal slices prepared as described 
in the previous paragraph were cultured for 6 d on 0.4-μm Millicell-CM 
  organotypic inserts (Millipore) in MEM containing 25% horse serum, 
25% HBSS, and 0.65% dextrose. Slices were then transfected (80 pounds 
per square inch) with pSSRα/farnesylated enhanced GFP (EGFP-F; control), 
Cas/EGFP-F, Cas∆SD/EGFP-F, Cas∆SH3/EGFP-F, or Cas∆SB/EGFP-F 
plasmids ((25 μg Cas plasmid mixed with 20 μg EGFP-F plasmid coated 
onto 25 mg of 1.6-μm gold particles; Nakamoto et al., 1996). Cas plas-
mids were provided by K. Vuori and A. Motoyama (Burnham Institute for 
Medical Research, La Jolla, CA). After 48 h, the slices were ﬁ  xed in 4% 
PFA in 0.1 M PBS for 30 min before z-series imaging of dendrites from 
transfected CA1 pyramidal neurons. For integrin inhibition, 170 μM RGDFV 
or RADFV (control) peptide (BIOMOL Research Laboratories, Inc.) was 
added to the media of EGFP-F–transfected cultured hippocampal slices. After 
an additional 24 h in culture, the slices were analyzed either by confocal 
z-series imaging or immunoblotting.
Cas siRNA knockdown
Four siRNAs for mouse Cas were obtained from Dharmacon, including 
siCas #1 (G  C  A  T  A  G  G  G  C  A  T  G  A  C  A  T  C  T  A  ; nucleotides 678–696; GenBank/
EMBL/DDBJ accession no. NM_009954), siCas #2 (A  G  A  C  G  G  A  G  C  A  G  G-
A  T  G  A  G  T  A  ; nucleotides 804–822), siCas #3 (C  C  G  A  G  G  A  A  G  T  C  C  A  G  G  A  -
T  T  C  , nucleotides 1,816–1,834), and siCas #4 (G A  T  T  C  T  G  G  T  T  G  G  C  A  T  G  T  A  , 
nucleotides 292–310). Two scrambled siRNAs (nontargeting siRNA #1 
and #2; Dharmacon) were used as controls. To obtain the pEGFP-hCas 
vec  tor, human Cas cDNA (GenBank/EMBL/DDBJ accession no. BC062556; 
Open Biosystems) was ampliﬁ  ed by PCR with the forward primer 5′-G  C  T  A  G-
C  C  T  C  G  A  G  C  A  T  G  A  A  C  C  A  C  C  T  G  A  A  C  G  T  -3′ and the reverse primer 5′-G  C  T  A  G-
C  G  A  A  T  T  C  T  C  A  G  G  C  G  G  C  T  G  C  C  A  G  A  C  A  -3′. The PCR product was digested 
and inserted into the XhoI and EcoRI sites of pEGFP-C2 (BD Biosciences) 
and veriﬁ  ed by sequencing.
Hippocampal slices were cotransfected with the siRNAs and the 
indicated plasmid using a gene gun as described previously (Boda et al., 
2004; Govek et al., 2004). 24 μg of duplex siRNA and 12 μg of plasmid 
were mixed and coated onto 10 mg of 1.6-μm gold particles. Transfected 
(green ﬂ  uorescent) dendrites were analyzed 2 d after transfection by confo-
cal z-series imaging. The effectiveness of siRNA transfection into hippo-
campal pyramidal neurons was veriﬁ   ed by using a rhodamine-labeled 
siRNA transfected together with EGFP-F. The effectiveness of Cas knock-
down by the siRNAs and the rescue of Cas expression by EGFP-hCas was 
veriﬁ  ed in NIH3T3 cells. Cells were plated at 80% conﬂ  uency, cultured 
overnight in DME and 10% bovine calf serum, and transfected in Opti-
MEM with 78 nM siRNAs (with or without plasmids) using LipofectAMINE 
2000 (Invitrogen). After 4 h, the medium was replaced by the DME culture 
medium, and Cas expression was assessed after 48 h by immunoblotting 
of cell lysates.
Quantiﬁ  cation of spine dimensions and shape
Images were collected using a confocal microscope (MRC 1024; Bio-Rad 
Laboratories) and analyzed using ImageJ 1.62 software (National Insti-
tutes of Health [NIH]), and the analysis of spines was conﬁ  ned to sec-
ondary and tertiary dendrites from the stratum radiatum. Quantiﬁ  cation of 
spine lengths and widths was performed as described previously (Murai 
et al., 2003). In brief, the length was measured from the tip of spine head 
to the interface with the dendritic shaft. The width was taken as a diameter 
of the spine head perpendicular to the length of the spine. Spines were 
assigned to morphological categories as described previously (Maruoka 
et al., 2005) by an investigator blind to the conditions. Mushroom spines 
are <2 μm in length, >0.5 μm in width, and are connected to the den-
dritic shaft by a narrower portion (neck). Stubby spines are <2 μm in 
length, >0.5 μm in width, and lack a deﬁ  ned neck. Thin spines are <2 μm 
in length, <0.5 μm in width, and have a neck. Filopodia spines are >2 μm 
in length, <0.5 μm in width, and do not have a distinct spine head. 
Irregular spines are branched spines (two heads and two necks merged 
into a single neck at the base) and multilobed spines (many heads fused 
together on top of a single neck). All measurements were obtained by 
counting 478–2,182 spines per condition (from 6–13 neurons) from in-
dependent experiments. Spine cumulative distributions were compared 
using the Kolmogorov-Smirnov test, and means were compared using the 
t test or analysis of variance (ANOVA) test followed by Dunnett’s, Tukey’s, 
or Bonferroni’s posthoc tests.
Cell attachment assays
To obtain the EphA4-B35 cells, the rat B35 neuronal-like cell line (Schubert 
et al., 1974) was transfected with the EphA4 cDNA in pcDNA3 using 
SuperFect (QIAGEN) and selected for 2 wk with 500 μg/ml G418. To 
perform the cell attachment assays, the HT22 hippocampal neuron cell 
line (Li et al., 1997) or EphA4-B35 cells were starved overnight in DME 
with 1% BSA, detached, and kept in suspension for 30 min at 37°C in 
DME–1% BSA. Cells (7 × 10
4 cells per well of a 12-well plate) were then 
allowed to attach to poly-L-lysine– (20 μg/ml; Sigma-Aldrich) or ﬁ  bronectin-
coated coverslips (20 μg/ml ﬁ  bronectin for EphA4-B35 and 10 μg/ml 
for HT22; Chemicon) for 10 min at 37°C in the presence of 10 μg/ml 
Fc or 10 μg/ml ephrin-A3 Fc. Attached cells were fixed in 4% PFA, 
stained with DAPI (Invitrogen), and counted blind (seven to nine 20× 
microscope ﬁ  elds were counted per condition). To determine Cas phos-
phorylation, both adherent and nonadherent cells were pooled, lysed, and 
probed by immunoblotting. HT22 and B35 cell lines were provided by 
W. Stallcup and B. Moosmann (Burnham Institute for Medical Research, 
La Jolla, CA), respectively.
Determination of activated and cell surface 𝗃1 integrins
HT22 was starved and plated on tissue culture plates coated with 
10 μg/ml ﬁ  bronectin for 1 h at 37°C in the presence of 10 μg/ml Fc, 
10 μg/ml ephrin-A3 Fc, or 1 mM MnCl2. To determine the levels of acti-
vated β1 integrin, live cells were rinsed with PBS and incubated with 
2 μg/ml 9EG7 rat monoclonal antibody or control rat IgG for 15 min at 
37°C. Cells were rinsed with PBS and lysed in SDS sample buffer, and 
bound antibodies were detected by immunoblotting with biotin-conjugated 
anti–rat IgG antibody (Vector Laboratories) followed by HRP-streptavidin 
(Zymed Laboratories). To determine the levels of cell surface β1 integrin, 
cells were washed with PBS, and surface proteins were labeled with 1 mM 
sulfosuccinimidyl-6-(biotin-amido)hexanoate (Pierce Chemical Co.) for 
30 min at 4°C. Cells were washed with PBS and lysed in Hepes buffer 
with protease inhibitors, and biotin-labeled proteins were incubated 
with 50 μl streptavidin-conjugated beads (Biochemika) for 1 h at 4°C. 
Bound proteins were eluted and analyzed by immunoblotting with anti–β1-
integrin antibodies.JCB • VOLUME 178 • NUMBER 7 • 2007  1306
Animal approval
Protocols for the animal studies were approved by the Burnham Institute’s 
Animal Research Committee.
Online supplemental material
Fig. S1 summarizes the quantiﬁ  cation and statistical analysis of the data from 
immunoblotting experiments. Fig. S2 conﬁ  rms that ephrin-A3 Fc decreases 
Cas tyrosine phosphorylation in hippocampal slices from EphA4
+/− mice 
but not in slices from EphA4
−/− mice. Fig. S3 conﬁ  rms that Cas knockdown 
decreases dendritic spine density and length in hippocampal slices by using 
a second siRNA control. Fig. S4 shows that the expression of human Cas 
abrogates the effects of mouse Cas siRNA on dendritic spine morphology. 
Fig. S5 demonstrates that integrin activation with Mn
2+ blocks ephrin-A3 
Fc–induced spine changes. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200610139/DC1.
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